Literature DB >> 11073496

Pitfalls of pharmacoepidemiology.

D C Skegg.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11073496      PMCID: PMC1118945          DOI: 10.1136/bmj.321.7270.1171

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

1.  The UK General Practice Research Database.

Authors:  T Walley; A Mantgani
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

2.  Calcium-channel blockers and risk of cancer.

Authors:  H Jick; S Jick; L E Derby; C Vasilakis; M W Myers; C R Meier
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

3.  Use of the UK General Practice Research Database for pharmacoepidemiology.

Authors:  L A García Rodríguez; S Pérez Gutthann
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

5.  A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; J C Todd; T J Williams; K D MacRae; F Tyrer; G M Leydon
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

6.  Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.

Authors:  H Jick; J A Kaye; C Vasilakis-Scaramozza; S S Jick
Journal:  BMJ       Date:  2000-11-11

7.  Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; C R Thompson; J G Kennedy; I R Hambleton
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

8.  Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.

Authors:  R D Farmer; T J Williams; E L Simpson; A L Nightingale
Journal:  BMJ       Date:  2000 Aug 19-26

9.  Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Authors:  H Jick; S S Jick; V Gurewich; M W Myers; C Vasilakis
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

10.  Antidepressants and suicide.

Authors:  S S Jick; A D Dean; H Jick
Journal:  BMJ       Date:  1995-01-28
View more
  5 in total

1.  Pitfalls of pharmacoepidemiology.

Authors:  R Farmer; T Williams; A Nightingale
Journal:  BMJ       Date:  2000-11-25

2.  Oral contraceptives, venous thromboembolism, and the courts.

Authors:  David C G Skegg
Journal:  BMJ       Date:  2002-09-07

3.  An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

Authors:  Andrea Clarke; Jonathan J Deeks; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 5.  Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?

Authors:  James Drife
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.